• To prevent and treat cardiovascular disease in Africa • To educate and train African healthcare professionals in cardiovascular disease 1 • To educate laypersons about heart disease • To invest in cardiovascular research 2 To achieve these aims, there are nine task-forces, leading the scientific and research arms of PASCAR. These are:
• Sudden Cardiac Death • Rheumatic Heart Disease • Pan African Network for Paediatric and Congenital Heart (PANPACH) The most recent PASCAR congress was held from 7 to 11 October 2017 in conjunction with the Sudan Heart Society and the Pan-African Course on Interventional Cardiology (PAFCIC) in Khartoum, Sudan. It was preceded by several workshops and ended with the African Summit on Circulatory Disease, hosted by the World Heart Federation.
PANPACH held their first independent workshop at this meeting and herewith, a report of that event.
PANPACH consists of paediatric cardiologists, cardiac surgeons, and paediatricians or general physicians with an interest in cardiology. Like PASCAR, PANPACH has four major related aims: first, to prevent and treat children's heart disease in Africa; second, to educate and train African healthcare professionals about children's heart disease; third, to educate laypersons about children's heart disease; and fourth, to invest in children's heart disease research. An additional aim is to form a network of persons who are passionate about managing and controlling children's heart disease in Africa.
The Prof Ali, ever the optimist, also described this as a success, if not for Sudan, at least for the region and the world.
There were two outstanding fellow presentations. The first from Dr Hassan Awadalla, who presented a paper on 'The Sudan Hand held echocardiography Project: A tool for surveillance and control of Rheumatic Heart Disease (RHD)'. Particularly interesting in this paper, was new evidence of a very high incidence of latent RHD in the Kordofan and White Nile regions of Sudan, which is further confirmed by the high number of cases from these areas in hospital registers. In addition, he presented the results of over 2700 adults screened for asymptomatic RHD.
Dr Intisar Ibrahim presented the work of colleagues' Dr Tajudeen Bushari and Prof Sulafa Ali in examining the validation of the accuracy of hand-held echocardiography for the diagnosis of congenital heart disease. This was an example of 'research for life' hand-held echocardiography devices donated for RHD surveillance and screening now being used for the diagnosis of congenital heart disease, using a modified segmental approach, as echo machines are a scares resource in Sudan, and demonstrating excellent overall diagnostic accuracy.
The founder of Paediatric Cardiology in Sudan, Prof Moneim Elseed gave the participants a fascinating overview of the beginnings of paediatric cardiology in Sudan, discussed some of the challenges faced by the previous generation and the approaches taken and addressed the current needs, gaps and opportunities. Key concerns are the lack of paediatric cardiac surgeons (only one in Sudan) as well as few anaesthetists and intensivists trained in paediatrics.
The following sessions featured two papers from Uganda and one from Ghana. Dr Suleiman Lubega, Head of the Division of Paediatric Cardiology in Kampala, Uganda, outlined the strategy involved in the development of the paediatric program at the Uganda Heart Institute (UHI). The UHI has recently been awarded a unique independent status within Uganda and has over the past decade been able to develop a local surgical program with 100 independent cases planned for 2017. Integrated in the system is teaching, telemedicine and research. Dr Nana Yao is the sole paediatric cardiologist in Ghana. She is a Ghanaian but raised in Dublin and trained in London and Birmingham. After a chance meeting with Dr Frank Edwin, a cardiac surgeon trained in South Africa and working in Accra, Dr Yao decided to relocate to Ghana and now is head of the unit in Accra. As the sole practitioner, she has significant challenges but has developed several cardiac clinics, and oversees the paediatric surgical cardiac patients operated on in Ghana.
The final presentation in this session was a review of the Paediatric Cardiology program in Gulu, Uganda, presented by Dr Lubega on behalf of the head of the unit, Dr Twalib Aliku. Dr Lubega discussed the echocardiographic characteristics of patients seen in Gulu and the referral process between Gulu and Kampala, Uganda. A total of 299 children were diagnosed with CHD during the period, mean age of patients with CHD was 3.1 years, 59.2% female. Already at initial evaluation, 75% (224/299) of the children needed definitive intervention. Dr Aliku was the first paediatric cardiologist to be trained by the Uganda Heart Institute. He completed a Master of Medicine in Paediatrics and Child Health at Makerere University, followed by fellowships in India and the US. This session outlined the establishment of new units in Africa and the brisk discussion that followed examined challenges, learning lessons and new innovative approaches to growth and maintenance of these fledgling units.
The final session commenced with Prof Toure Ali, Niger presenting a paper on the 'Screening of cardiovascular diseases in primary schools in Niamey (Niger-West Africa): A prospective cross-sectional survey in 5236 pupils'. This study reported on a surveillance study screening for heart disease and hypertension in schools in Niger. There were 78 cases of heart diseases (14.9%), most frequent was RHD (48 cases, 9.2%), congenital heart disease (8 cases, 1.5%) and severe anaemia (22 cases, 4.2%). The prevalence of high blood pressure was 7.2% and metabolic syndrome 14.6%. These data suggest that preventive measures should be taken to prevent cardiovascular disease with educational and nutritional programs including nurses, school educators and families at community level.
Prof Liesl Zühlke from South Africa then presented the findings of a retrospective study of 109 Grown-Up Congenital Heart Disease (GUCH) patients operated in Cape Town, South Africa.
6 GUCH is a rapidly growing population in Africa and needs a comprehensive strategy and multi-disciplinary team approach. Although Group A Streptococcus (GAS) is a significant cause of morbidity and mortality on the global scale especially with the sequelae of RHD, the burden of GAS disease in Africa is not known. Prof Mark Engel from Cape Town presented the rationale and design of the Afrostrep registry-the registry will enrol both passive and active surveillance of GAS and is attempting to inform current prevention efforts including vaccine development. In the final presentation, Prof Zühlke presented the Protea Registry (Partnerships in Congenital Heart disease in Africa) a new initiative to build a comprehensive congenital heart disease registry in Africa. Commencing in South Africa, and in partnership with Manchester University and funded by a Medical Research Council-UK seed grant, the registry aims to characterize CHD patients (children and adults), in Cape Town in the first instance, develop a comprehensive clinical, genotypic/phenotypic, demographic and outcomes database, and establish a biobank of samples for DNA extraction and genetic analysis. Two important additional aims are to train junior African researchers and to foster multidisciplinary collaboration in CHD.
The day closed with a prize-giving: the best abstract was awarded to Dr Intisar Ibrahim for the presentation of the work of colleagues' Dr Tajudeen Bushari and Prof Salafa Ali in examining the accuracy of hand held echocardiography for the diagnosis of congenital heart disease.
All present felt that the workshop had been highly successful as a first step to committing ourselves to a new era of collaboration and networking to improve the lives of children with heart disease in Africa. 
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